CD69 and cancer: The total frequencies of CD69+CD49a+CD103−CD16−, CD69+CD49a−CD103+CD16−, and CD69+CD49a+CD103+CD16− NK cells detected were independent of clinical parameters, including medication and type of cancer of patients from whom clinical samples were derived (Supplementary Fig. 2a–c).